Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases

Abstract

ContextDyslipidemia, including elevated serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), and triglycerides (TG), and low high density lipoprotein cholesterol (HDL-C) is a major modifiable risk factor for non-communicable diseases (NCDs). This review summarizes many of the key findings on lipid measures in the Tehran lipid and glucose study (TLGS), a large scale community-based study with an approximately two decade follow-up.Evidence AcquisitionA systematic literature search was conducted using PubMed, Scopus, Web of Science databases, and the library of the Research Institute for Endocrine Sciences, using the following keywords: Lipid measures, lipid ratios, lipid profile, dyslipidemia, and “Tehran lipid and glucose study”. Articles were categorized based on fields of prevalence, trends, and impact of lipid profile on incident NCDs and mortality.ResultsBetween 1999 - 2001, the prevalence of high risk lipids ranged from 14% (low HDL-C) to 17% (high LDL-C) among adolescents, although among adults the lowest and highest prevalence were observed for low HDL-C (19%) and high TG (28%). Despite favorable trends for lipid parameters among adolescents, adults, and the elderly population, a considerable number of diabetic individuals, failed to achieve the optimum level of serum lipids. During follow-up, consumption of lipid-lowering drugs increased from 1.5 to 9.0% and 3.7 to 11.4% among adult men and women, respectively. The association between different lipid parameters and related ratios for incident type 2 diabetes (T2D), hypertension, metabolic syndrome and cardiovascular diseases differed between genders. Interestingly, each 1-unit increase in TC/HDL-C increased risk of hypertension among women (odds ratio (OR): 1.19, 95% confidence interval (CI): 1.00 - 1.27) and T2D among men (OR: 1.27, 95% CI: 1.06 - 1.51). Moreover, TC, LDL-C, non-HDL-C, Ln-TG, TC/HDL-C, and Ln-TG/HDL were inversely associated with non-cardiovascular mortality.ConclusionsDespite high prevalence of high risk lipid profiles among the TLGS population at baseline, favorable trends were observed in levels of all lipid components, which might be attributable to increased consumption of lipid-lowering medications and improvement in the general knowledge of Iranians regarding limited consumption of hydrogenated oil. Considering the impact of lipid profiles on incident NCDs, more attention should be paid to at-risk groups for screening and treatment purposes.

Impaired fasting glucose prevalence surge among Iranian adolescents in a decade: The Tehran Lipid and Glucose Study

“…We showed a 2-fold rise in IFG, from 7% in 1999 to The favorable trend in lipid profiles and blood pressure, despite increasing levels of general and central adiposity in our study population has also been shown in previous studies conducted among Iranian adolescents. [25][26][27][28] This trend might be a consequence of a regulatory program designed by the Ministry of Health [29][30][31] to limit the consumption of salt, fat in general as well as trans-fatty acids (TFA).…”

Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans

“…Despite the high prevalence of dyslipidemia, obesity, and unhealthy lifestyle in Iran, lipid profile has a favorable trend. This control of lipids is mainly explained by lower consumption of saturated and hydrogenated oil and higher usage of liquid oil, implemented by the government [ 47 , 48 ]. More public education and screening plans for intermediate- and high-risk groups are needed to control this risk factor effectively.…”

The Effects of Baduanjin Exercise on BMI, Waist-Hip Ratio and Lipids Among Perimenopausal Women

“…Risk factors for cardiovascular disease (CVD) are higher than women of childbearing age. Appropriate lifestyle changes can prevent from CVD such as healthy diet, quitting smoking, regular exercise and maintaining proper weight (Baghbani-Oskouei, Tohidi, Asgari, Ramezankhani, Azizi & Hadaegh, 2018;Colpani, et al, 2018;Ford, Zhao, Tsai & Li, 2011;Gurka, Vishnu, Santen & DeBoer, 2016;Hashemi Nazari, Shakiba , Khalili, Hadaegh, Tohidi & Azizi, 2015;Hunter, Hardy, Norton & Griffiths, 2016;Palacios et al, 2010;Mc Sweeney et al, 2016;Muka et al, 2016;Mumusoglu & Yildiz, 2019;Nejat et al, 2014;Tabatabaei-Malazy et al, 2018). Several studies have shown that in postmenopausal women "excess waist circumference or abdominal obesity", "overweight and obese" hypertension, dyslipidemia, hyperglycemia, and high abdominal obesity rates are closely related to the prevention and treatment of CVD and health promotion.…”